Genetic Technologies

Australia
Fitzroy North, Victoria, Australia, 3065

Company profile

Genetic Technologies company profile

Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services. Our aim is simple: to concentrate on markets where we can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. We are already the leading non-government genetic testing business in Australia, and through our wholly owned subsidiary Phenogen Sciences, we now have a solid and growing presence in the USA. We remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.

Business identity

Contact email
[email protected]
Phone number
+61 3 8412 7000
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
1987-01-01, Year

Headquarters

Postal code
3065
Country code
AU
Continent
Oceania

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$38.1M
Last funding
Post IPO Equity / $2M / 2024-04-18
Last equity funding
Post IPO Equity / $2M
Investors
1
Lead investors
1
Articles
51
Exited on
1998-07-21

Founders and investors

Lead investors

Kentgrove Capital

Investors

Kentgrove Capital